Cardiovascular Safety of Anagrelide Hydrochloride versus Hydroxyurea in Essential Thrombocythaemia

द्वारा Gotic, Mirjana, Egyed, Miklos, Gercheva, Liana, Warzocha, Krzysztof, Kvasnicka, Hans Michael, Achenbach, Heinrich, Wu, Jingyang
में प्रकाशित Cardiovasc Toxicol (2020)

Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient—case report

द्वारा Prenek, Lilla, Csupor, Klára, Beszterczán, Péter, Boros, Krisztina, Kardos, Erika, Vorobcsuk, András, Egyed, Miklós, Kellner, Ádám, Rajnics, Péter, Varga, Csaba
में प्रकाशित Int J Emerg Med (2021)

Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma

द्वारा Ludwig, Heinz, Adam, Zdenek, Tóthová, Elena, Hajek, Roman, Labar, Boris, Egyed, Miklós, Spicka, Ivan, Gisslinger, Heinz, Drach, Johannes, Kuhn, Ingrid, Hinke, Axel, Zojer, Niklas
प्रकाशित 2010

Ruxolitinib for the treatment of inadequately controlled polycythemia vera without splenomegaly: 80-week follow-up from the RESPONSE-2 trial

द्वारा Griesshammer, Martin, Saydam, Guray, Palandri, Francesca, Benevolo, Giulia, Egyed, Miklos, Callum, Jeannie, Devos, Timothy, Sivgin, Serdar, Guglielmelli, Paola, Bensasson, Caroline, Khan, Mahmudul, Ronco, Julian Perez, Passamonti, Francesco
में प्रकाशित Ann Hematol (2018)

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations

द्वारा Andrikovics, Hajnalka, Krahling, Tunde, Balassa, Katalin, Halm, Gabriella, Bors, Andras, Koszarska, Magdalena, Batai, Arpad, Dolgos, Janos, Csomor, Judit, Egyed, Miklos, Sipos, Andrea, Remenyi, Peter, Tordai, Attila, Masszi, Tamas
प्रकाशित 2014

Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial

द्वारा Montillo, Marco, Illés, Árpád, Robak, Tadeusz, Pristupa, Alexander S., Wach, Malgorzata, Egyed, Miklós, Delgado, Julio, Jurczak, Wojciech, Morschhauser, Franck, Schuh, Anna, Eradat, Herbert, Shreay, Sanatan, Barrientos, Jacqueline C., Zelenetz, Andrew D.
में प्रकाशित Health Qual Life Outcomes (2019)

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor–Naïve Patients With Myelofibrosis

द्वारा Mesa, Ruben A., Kiladjian, Jean-Jacques, Catalano, John V., Devos, Timothy, Egyed, Miklos, Hellmann, Andrzei, McLornan, Donal, Shimoda, Kazuya, Winton, Elliott F., Deng, Wei, Dubowy, Ronald L., Maltzman, Julia D., Cervantes, Francisco, Gotlib, Jason
में प्रकाशित J Clin Oncol (2017)

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups

द्वारा Gisslinger, Heinz, Klade, Christoph, Georgiev, Pencho, Krochmalczyk, Dorota, Gercheva-Kyuchukova, Liana, Egyed, Miklos, Rossiev, Viktor, Dulicek, Petr, Illes, Arpad, Pylypenko, Halyna, Sivcheva, Lylia, Mayer, Jiri, Yablokova, Vera, Krejcy, Kurt, Hasselbalch, Hans C., Kralovics, Robert, Kiladjian, Jean-Jacques
में प्रकाशित Hemasphere (2020)

Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia

द्वारा Newland, Adrian C., Sánchez‐González, Blanca, Rejtő, László, Egyed, Miklos, Romanyuk, Nataliya, Godar, Marie, Verschueren, Katrien, Gandini, Domenica, Ulrichts, Peter, Beauchamp, Jon, Dreier, Torsten, Ward, E. Sally, Michel, Marc, Liebman, Howard A., de Haard, Hans, Leupin, Nicolas, Kuter, David J.
में प्रकाशित Am J Hematol (2019)

Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

द्वारा Mesa, Ruben A, Vannucchi, Alessandro M, Mead, Adam, Egyed, Miklos, Szoke, Anita, Suvorov, Aleksandr, Jakucs, Janos, Perkins, Andrew, Prasad, Ritam, Mayer, Jiri, Demeter, Judit, Ganly, Peter, Singer, Jack W, Zhou, Huafeng, Dean, James P, te Boekhorst, Peter A, Nangalia, Jyoti, Kiladjian, Jean-Jacques, Harrison, Claire N
में प्रकाशित Lancet Haematol (2017)

Idelalisib or Placebo in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refractory CLL - Interim Results of a Phase 3 Randomized, Double-blind Placebo-Contro...

द्वारा Zelenetz, Andrew D., Barrientos, Jacqueline C., Brown, Jennifer R., Coiffier, Bertrand, Delgado, Julio, Egyed, Miklós, Ghia, Paolo, Illés, Árpád, Jurczak, Wojciech, Marlton, Paula, Montillo, Marco, Morschhauser, Franck, Pristupa, Alexander S., Robak, Tadeusz, Sharman, Jeff P., Simpson, David, Smolej, Lukáš, Tausch, Eugen, Adewoye, Adeboye H., Dreiling, Lyndah K., Kim, Yeonhee, Stilgenbauer, Stephan, Hillmen, Peter
में प्रकाशित Lancet Oncol (2017)

Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia

द्वारा Ravandi, Farhad, Ritchie, Ellen K., Sayar, Hamid, Lancet, Jeffrey E., Craig, Michael D., Vey, Norbert, Strickland, Stephen A., Schiller, Gary J., Jabbour, Elias, Pigneux, Arnaud, Horst, Heinz-August, Récher, Christian, Klimek, Virginia M., Cortes, Jorge E., Carella, Angelo-Michele, Egyed, Miklos, Krug, Utz, Fox, Judith A., Craig, Adam R., Ward, Renee, Smith, Jennifer A., Acton, Gary, Kantarjian, Hagop M., Stuart, Robert K.
में प्रकाशित Haematologica (2018)

The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria

द्वारा Röth, Alexander, Nishimura, Jun-ichi, Nagy, Zsolt, Gaàl-Weisinger, Julia, Panse, Jens, Yoon, Sung-Soo, Egyed, Miklos, Ichikawa, Satoshi, Ito, Yoshikazu, Kim, Jin Seok, Ninomiya, Haruhiko, Schrezenmeier, Hubert, Sica, Simona, Usuki, Kensuke, Sicre de Fontbrune, Flore, Soret, Juliette, Sostelly, Alexandre, Higginson, James, Dieckmann, Andreas, Gentile, Brittany, Anzures-Cabrera, Judith, Shinomiya, Kenji, Jordan, Gregor, Biedzka-Sarek, Marta, Klughammer, Barbara, Jahreis, Angelika, Bucher, Christoph, Peffault de Latour, Régis
में प्रकाशित Blood (2020)

Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis

द्वारा Gerds, Aaron T., Savona, Michael R., Scott, Bart L., Talpaz, Moshe, Egyed, Miklos, Harrison, Claire N., Yacoub, Abdulraheem, Vannucchi, Alessandro, Mead, Adam J., Kiladjian, Jean-Jacques, O’Sullivan, Jennifer, García-Gutiérrez, Valentin, Bose, Prithviraj, Rampal, Raajit K., Miller, Carole B., Palmer, Jeanne, Oh, Stephen T., Buckley, Sarah A., Mould, Diane R., Ito, Kaori, Tyavanagimatt, Shanthakumar, Smith, Jennifer A., Roman-Torres, Karisse, Devineni, Sri, Craig, Adam R., Mascarenhas, John O.
में प्रकाशित Blood Adv (2020)

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 tr...

द्वारा Sharman, Jeff P, Egyed, Miklos, Jurczak, Wojciech, Skarbnik, Alan, Pagel, John M, Flinn, Ian W, Kamdar, Manali, Munir, Talha, Walewska, Renata, Corbett, Gillian, Fogliatto, Laura Maria, Herishanu, Yair, Banerji, Versha, Coutre, Steven, Follows, George, Walker, Patricia, Karlsson, Karin, Ghia, Paolo, Janssens, Ann, Cymbalista, Florence, Woyach, Jennifer A, Salles, Gilles, Wierda, William G, Izumi, Raquel, Munugalavadla, Veerendra, Patel, Priti, Wang, Min Hui, Wong, Sofia, Byrd, John C
में प्रकाशित Lancet (2020)

Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study

द्वारा Maerevoet, Marie, Zijlstra, Josee M., Follows, George, Casasnovas, Rene-Olivier, Vermaat, J. S. P., Kalakonda, Nagesh, Goy, Andre, Choquet, Sylvain, Van Den Neste, Eric, Hill, Brian, Thieblemont, Catherine, Cavallo, Federica, De la Cruz, Fatima, Kuruvilla, John, Hamad, Nada, Jaeger, Ulrich, Caimi, Paolo, Gurion, Ronit, Warzocha, Krzysztof, Bakhshi, Sameer, Sancho, Juan-Manuel, Schuster, Michael, Egyed, Miklos, Offner, Fritz, Vassilakopoulos, Theodoros P., Samal, Priyanka, Ku, Matthew, Ma, Xiwen, Corona, Kelly, Chamoun, Kamal, Shah, Jatin, Shacham, Sharon, Kauffman, Michael G., Canales, Miguel
में प्रकाशित J Hematol Oncol (2021)